Patrick McEnany is the CEO and co-founder of Catalyst Pharmaceuticals. The company is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS.
Patrick McEnany is the CEO and co-founder of Catalyst Pharmaceuticals. The company is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF
Patrick McEnany is the CEO and co-founder of Catalyst Pharmaceuticals. The company is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF

The big gamble: Catalyst Pharmaceuticals of Coral Gables bets on new drug for rare disease

July 18, 2015 03:00 PM

UPDATED July 20, 2015 11:13 PM

More Videos

  • Company manufactures American flags in South Florida

    Barbara Dabney runs a flag and banner company. Her staff works making American flags for various national holidays including the 4th of July.